PT  - JOURNAL ARTICLE
AU  - Brackstone, Ken
AU  - Atengble, Kirchuffs
AU  - Head, Michael G
AU  - Boateng, Laud A
TI  - COVID-19 Vaccine Hesitancy in Ghana: The Roles of Political Allegiance, Misinformation Beliefs, and Sociodemographic Factors
AID  - 10.1101/2022.03.16.22272463
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.16.22272463
4099  - http://medrxiv.org/content/early/2022/07/01/2022.03.16.22272463.short
4100  - http://medrxiv.org/content/early/2022/07/01/2022.03.16.22272463.full
AB  - The vast majority of people in the world who are unvaccinated against COVID-19 reside in LMIC countries in sub-Saharan Africa. This includes Ghana, where only 15.9% of the country are fully vaccinated as of April 2022. A key factor negatively impacting vaccination campaigns is vaccine hesitancy, defined as the delay in the acceptance, or blunt refusal, of vaccines. Four online cross-sectional surveys of Ghanaian citizens were conducted in August 2020 (N = 3048), March 2021 (N = 1558), June 2021 (N = 1295), and February 2022 (N = 424) to observe temporal trends of vaccine hesitancy in Ghana, and to examine key groups associated with hesitancy. Overall hesitancy decreased from 36.8% (95% CI: 35.1%-38.5%) in August 2020 to 17.2% (95% CI: 15.3%-19.1%) in March 2021. However, hesitancy increased to 23.8% (95% CI: 21.5%-26.1%) in June 2021, and then again to 52.2% (95% CI: 47.4%-57.0%) in February 2022. Key reasons included not having enough vaccine-related information (50.6%) and concerns over vaccine safety (32.0%). Hesitant groups included Christians, urban dwellers, opposition political party voters, people with more years of education, females, people who received COVID-19 information from internet sources, and people who expressed uncertainty about COVID-19 misinformation beliefs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Economic and Social Research Council Impact Acceleration Account (ESRC IAA) and the UKRI Global Challenges Research Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The surveys received ethical approvals from University of Southampton Ethics Committee (ERGO ID: 57267).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data collected are available on the OSF https://osf.io/r72hw/